LYCOS RETRIEVER 
Chiron: Research
built 207 days ago
Once the HCV genome was identified, Chiron launched research efforts to develop products to diagnose HCV infection and screen for HCV in the blood supply. In a remarkably short period, the team produced diagnostic antigens that detected antibody circulating in the blood of infected individuals and developed these antigens into a series of HCV blood-screening kits first brought to market in 1989. Now used globally to screen blood donors, these HCV tests have reduced the risk of acquiring hepatitis C following transfusion from 5% in 1990 to approximately 0.002% today. It has been estimated that the use of these HCV tests in the USA alone results in more than 50,000 individuals each year avoiding infection with HCV.
Source:
Chiron's scientists in 1987 developed a technique to clone multiple versions of the elusive hepatitis C virus, which allows researchers to easily generate billions of viruses to research. Chiron received a patent for the discovery three years later.
Source:
This is press release issued by Chiron corp. Following the press release is a notice that the FDA was investigating Chiron for complaints that they hinder HCV research due to requiring licensing fees for any HCV therapeutic research. Jules Levin, NATAP
Source:
MORE ABOUT
Research